This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
A large randomised assessment of the relative cost-effectiveness of different classes of drugs for Parkinson’s disease (PD MED)
Investments > €500k
United Kingdom
Parkinson’s disease & PD-related disorders
2016